NASDAQ:LAVA LAVA Therapeutics (LAVA) Stock Price, News & Analysis → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free LAVA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get LAVA Therapeutics alerts: Email Address Ad True Market Insidersget a piece of the profit from this land This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024. About LAVA Therapeutics Stock (NASDAQ:LAVA)Magma Design Automation, Inc. (Magma) provides electronic design automation (EDA) software products and related services. Its software enables chip designers to reduce the time it takes to design and produce integrated circuits used in the communications, computing, consumer electronics, networking and semiconductor industries. Its flagship products consist of a digital integrated solution for the chip development cycle, from initial design through physical implementation. Magma’s flagship Talus family of products, its Tekton static timing analyzer and QCP extractor and, its Quartz family of sign-off and verification tools combine into one integrated chip design and verification flow, from what has been separate logic design, physical design, and analysis and sign-off processes. Its Titan platform for custom integrated chip design provides an integrated chip-finishing solution for mixed-signal designs. In February 2012, Synopsys, Inc. acquired the Company.Read More Ad True Market Insidersget a piece of the profit from this land This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024. LAVA Stock News HeadlinesMarch 21, 2024 | markets.businessinsider.comStrong Buy Rating for LAVA Therapeutics on Promising Clinical and Financial OutlookMarch 21, 2024 | uk.finance.yahoo.comLAVA Therapeutics Full Year 2023 Earnings: Revenues DisappointMarch 20, 2024 | investorplace.comLVTX Stock Earnings: LAVA Therapeutics Misses EPS, Misses Revenue for Q4 2023March 17, 2024 | msn.comLiverpool XI vs Manchester United: Starting lineup, confirmed team news, injury latest for FA Cup todayMarch 16, 2024 | finance.yahoo.comLVTX Apr 2024 2.500 callMarch 5, 2024 | finance.yahoo.comLAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd2/LAVA-1223)February 26, 2024 | seekingalpha.comPRGS, EVER and LVTX are among after hour moversFebruary 2, 2024 | markets.businessinsider.comStrong Buy Rating for LAVA Therapeutics Amid Strategic Partnerships and Promising Clinical AdvancementsJanuary 25, 2024 | msn.comWhy Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionJanuary 25, 2024 | benzinga.comDow Surges Over 100 Points; US GDP Growth Tops EstimatesJanuary 25, 2024 | msn.comWhy Is Cancer Focused LAVA Therapeutics Nano Cap Stock Trading Higher Today?January 15, 2024 | msn.comNew Alzheimer’s Treatment Accelerates Removal of Plaque From The Brain In Clinical TrialsJanuary 13, 2024 | msn.comPsychedelics gave terminal patients relief from their intense anxietyNovember 27, 2023 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Genelux Corp. (GNLX), Calliditas Therapeutics (CALT)November 16, 2023 | finanznachrichten.deLAVA Therapeutics N.V.: Lava Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial ResultsNovember 16, 2023 | businesswire.comMemo Therapeutics AG Appoints Erik van den Berg as Chief Executive OfficerNovember 16, 2023 | msn.comLAVA Therapeutics GAAP EPS of -$0.34 beats by $0.14November 16, 2023 | finance.yahoo.comLava Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial ResultsNovember 15, 2023 | finance.yahoo.comK36 Therapeutics Announces Appointment of Benjamin Winograd, MD, PhD, as Chief Medical OfficerSeptember 21, 2023 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: US Physical Therapy (USPH), Calliditas Therapeutics (CALT)September 18, 2023 | benzinga.comDelveInsight Highlights Major Advances, Transformative Therapies, and 55+ Leading Players Wheeling the Chronic Lymphocytic Leukemia Pipeline LandscapeSeptember 6, 2023 | bizjournals.comPhiladelphia-area life sciences firms have now cut more than 500 jobs since the start of 2022September 6, 2023 | finance.yahoo.comLAVA Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment ConferenceAugust 23, 2023 | markets.businessinsider.comWhat 5 Analyst Ratings Have To Say About LAVA TherapeuticsAugust 23, 2023 | markets.businessinsider.comLAVA Therapeutics (LVTX) Gets a Buy from JMP SecuritiesSee More Headlines Receive LAVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LAVA Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:LAVA CUSIPN/A CIK1065034 Webwww.magma-da.com Phone+1-408-5657500FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:LAVA) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LAVA Therapeutics NV Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.